 Saint - Herblain France, June 23 , 2021 Valneva S E Nasdaq: VALN; Euronext Paris: VLA, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced today that all the resolutions recommended by the Management Board were approved by the shareholders at its Annual General Meeting AGM held as a closed session at its registered office on June 23, 2021. 